All In MedTech

FDA Clearance Tracker · P990020-S017

ANEURX STENT GRAFT WITH XCELERANT DELIVERY SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 28, 2004 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 28, 2004

Approved

Time to decision

85 days

Received Aug 4, 2004. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P990020-S017
Device name
ANEURX STENT GRAFT WITH XCELERANT DELIVERY SYSTEM
Applicant location
Santa Rosa, CA
Received
Aug 4, 2004
Decided
Oct 28, 2004
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P990020

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MODIFICATIONS MADE TO THE ANEURX DELIVERY SYSTEM, A CHANGE IN STERILIZATION METHOD, AND CHANGES TO THE INSTRUCTIONS FOR USE.

Source documents

Other decisions for Medtronic Vascular

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.